Guangrong Zheng

36PUBLICATIONS
104CO-AUTHORS
Haematological tumoursCharacterisation of biological macromoleculesMolecular targetsIndustrial molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jul 30, 2026
PROTAC-mediated targeting of IKKβ and NR4A1 for AML therapy.

|May 19, 2026
Fusaric Acid Analogs and Dimers from Marine-Derived Fusarium sp.: Biosynthetic Insights and Chloramphenicol-Enhanced Antibacterial Activity.

|Mar 28, 2026
The Combination of a BCL-xL PROTAC and an mTOR Inhibitor Sensitizes Pancreatic Ductal Adenocarcinoma to KRASG12D Inhibitor Treatment.

Javed Miyan, Vignesh Vudatha, Lin Cao

|Feb 23, 2026
Unveiling BCL-xL-specific PROTAC efficiency and dissociation pathways using native mass spectrometry.

Mohamed I Gadallah, Kailyn L Nonhof, Digant Nayak

|Feb 03, 2026
Development of PolyHis-Targeting PROTAC Degraders.

Hui Chen, Dong Zhu, Monica Billitti

|Oct 15, 2025
Quiescent OXPHOS-High Triple-Negative Breast Cancer Cells That Persist After Chemotherapy Depend on BCL-XL for Survival.

Slawomir Andrzejewski, Marie Winter, Leandro Encarnacao Garcia

Pageof 6

Frequent Collaborators

7 joint publications

Xuan Zhang

7 joint publications

Daohong Zhou

7 joint publications

Sajid Khan

6 joint publications

Dongwen Lv